Skip to content
  • Reports
  • Podcast
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » AiCuris

AiCuris

ADVERTISEMENT
News and Trends

Crack Open the Champagne, AiCuris’ Antiviral Launched in Germany

Update (23/02/2018): Merck Sharp & Dohme (MSD), licensee of AiCuris, has launched letermovir in Germany under…

By Alex Dale
23/02/2018 - 3 minutes
Best in Biotech

Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017

Now that we've got the bad news out of the way, we're here to spread…

By Alex Dale
18/12/2017 - 9 minutes
News and Trends

World Antibiotic Awareness Week: Here are Biotech’s Top 5 Strategies to Overcome Resistance

This week marks the WHO's World Antibiotic Awareness Week. We had a look at some of…

By Alex Dale
13/11/2017 - 3 minutes
News and Trends

Potential Herpes Cure from Germany Fast-Tracked for Patients with Weak Immune Systems

AiCuris' Pritelivir has now secured FDA endorsement in the form of a Fast Track Designation…

By Editorial Team
01/08/2017 - 2 minutes
In Depth

Rise of the Superbugs: How is Biotech Fighting Antibiotic Resistance?

Fewer antibiotics are produced as development costs rise. We reached out to a few companies…

By External Contributor
09/05/2017 - 8 minutes
News and Trends

This Herpes Cure is Proving to Work Better than its Predecessors

AiCuris' candidate pritelivir has shown to perform better than current standard antiviral treatments against genital…

By Clara Rodríguez Fernández
17/01/2017 - 2 minutes
News and Trends

Cold Sore Cure Company enters the Antibiotic Resistance fight

AiCuris is developing a new antibiotic that might bring hope for patients in which all…

By Clara Rodríguez Fernández
04/01/2017 - 2 minutes
News and Trends

German Record-deal Antiviral drug Succeeds in Phase III

AiCuris' Letermovir succeeds in Phase III after being licensed to MSD in a record €442.5M deal. It acts on a…

By Clara Rodríguez Fernández
20/10/2016 - 2 minutes
News and Trends

Update: Cold Sore Season is Here! AiCuris might have a Herpes Cure

Update (09/05/2017): AiCuris has started a Phase II trial, PRIOH-1, with the oral version of…

By Evelyn Warner
09/05/2016 - 2 minutes
News and Trends

Celebrating the 10th Birthday of this German Infectious Disease Biotech with the CEO

AiCuris is a Biotech company based on the Bayer Life Sciences park in Wuppertal (Germany).…

By Philip Hemme
15/02/2016 - 4 minutes
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Startups Gene therapy Synthetic biology
    Labiotech.eu
    Log In Newsletter

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast